Abstract
Syringomyelia is not a disease in its own right but a manifestation of another disease process, which incorporates either an obstruction of cerebrospinal fluid (CSF) flow in the spinal canal, tethering of the spinal cord, or an intramedullary tumor. Whenever a syrinx is demonstrated, clinical examination, analysis of the patient’s history, and neuroradiological imaging have to identify the underlying cause of the syrinx. If this cause can be identified and treated successfully, the syrinx will regress, and clinical symptoms will improve or remain stable in the future.
The significance of spinal arachnopathies for development and treatment of syringomyelia in patients without a craniospinal malformation, a spinal dysraphic malformation, or an intramedullary tumor is still not widely recognized. This chapter describes diagnostic and management algorithms for spinal arachnopathies leading to syringomyelia with a special emphasis on posttraumatic syringomyelia as well as long-term results for these patients.
Access provided by CONRICYT-eBooks. Download chapter PDF
Similar content being viewed by others
Keywords
- Arachnoiditis
- Posttraumatic syringomyelia
- Tethered cord syndrome
- Cerebrospinal fluid flow
- Intramedullary tumor
- Chiari malformation
1 Introduction
The term syringomyelia was introduced by Ollivier d’Angers in 1827 [35] for cystic cavitations of the spinal cord. Syringomyelia describes a progressive accumulation of fluid inside the spinal cord. Up to this day, no pathophysiological concept for the development of syringomyelia is generally accepted. However, with the introduction of modern imaging techniques in the 1970s and 1980s, it became clear that a syrinx is always associated with additional pathologies in the spinal canal or craniocervical junction. This observation has changed treatment concepts for these patients in a fundamental way. If the associated pathology can be treated successfully, no further measures for the syrinx are needed. It is now widely accepted that syringomyelia is related to intramedullary tumors or pathologies that cause a disturbance of cerebrospinal fluid (CSF) flow or spinal cord tethering, i.e., fixation of the cord to the spinal dura by a thick filum terminale or other dysraphic lesions [17]. Table 9.1 gives an overview on the different pathologies related to syringomyelia in the author’s series. About 74.5 % of patients with a Chiari I malformation developed a syrinx. Except for foramen magnum arachnoiditis, no other pathology causes syringomyelia in such a high proportion (Table 9.1).
Currently, syringomyelia is considered as an accumulation of extracellular fluid of the spinal cord [11, 17]. In case of intramedullary tumors, it is generally believed that alterations of the blood-spinal cord barrier play a major role [31]. But this may not be the only mechanism. It is noteworthy that infiltrating intramedullary tumors rarely produce syringomyelia, whereas a syrinx is a common feature of displacing neoplasms [24]. More information is available on the effects of CSF flow obstructions on the spinal cord from animal [27] as well as computer models [3]. Pressure changes in the subarachnoid space related to CSF flow obstructions may alter the distribution of extracellular fluid inside the spinal cord [27] which may then lead to syringomyelia [11, 17, 26]. Increased flow in the perivascular spaces has been implicated for this effect [2, 4, 17, 27, 43, 44]. If flow capacities in the extracellular space are exceeded, there appears to be an evolution from spinal cord edema, i.e., the so-called presyrinx state, to syringomyelia [8]. Intramedullary neoplasms and cord tethering may alter extracellular fluid movements to similar effects. Once syringomyelia has developed, the increased intramedullary pressure [32] and fluid movements inside the syrinx [1, 46] may lead to spinal cord damage [10, 39, 42] and progressive neurological symptoms.
2 Diagnosis
Intramedullary tumors associated with syringomyelia always display contrast enhancement on MRI. The most common entities are ependymomas (Fig. 9.1) and angioblastomas (Fig. 9.2). Whereas ependymomas associated with syringomyelia are solid space-occupying tumors, which are easily detected on MRI after application of gadolinium (Fig. 9.1), the diagnosis of an angioblastoma may not be straightforward. They tend to be localized in the dorsal root entry zone of the cord and may be quite small [24] (Fig. 9.2).
If tethered cord syndromes cause syringomyelia, these syrinx cavities tend to be rather small and of no clinical significance (Fig. 9.3). A large syrinx of the entire cord is rarely observed in patients with a tethered cord syndrome. The diagnostic challenge in these patients is the identification of all tethering elements, which tend to be localized below the lower pole of the syrinx. Such elements, which can be found in various combinations in a particular patient, are a thickened filum terminale, a split cord malformation (Fig. 9.3), or a lipoma fixed at the dura to mention the most frequent [19].
In patients with Chiari malformations, CSF flow can be compromised by cerebellar tonsils filling the space of the cisterna magna, by arachnoid scarring in the foramen magnum area, and by obstruction of the foramen of Magendie (Fig. 9.4). Whereas the obstruction by cerebellar tonsils is clearly apparent on a preoperative MRI, arachnoid adhesions and an obstruction of the foramen of Magendie are mostly intraoperative findings and need special attention during surgery [18].
In posttraumatic syringomyelia, CSF flow obstruction may be caused by arachnoid scarring at the trauma level as well as narrowing of the spinal canal due to posttraumatic stenosis or kyphosis (Fig. 9.5). Furthermore, posttraumatic cord tethering may contribute to syrinx development. Depending on associated injuries to vertebral bodies and joints, MRI may not be sufficient for surgical planning. CT scans in bone window technique may be very helpful to localize and determine bony landmarks for intraoperative orientation as well as the position of implants in patients who require a spondylodesis [21].
In the absence of a craniocervical malformation, an intramedullary tumor, or a history of spinal trauma, syringomyelia is still considered idiopathic by many physicians. However, these patients have to be evaluated very carefully for radiological and clinical signs of arachnoid pathologies in the spinal canal causing CSF flow obstructions [22] (Fig. 9.6). The syrinx starts at the level of obstruction and expands from there. If the syrinx expands in rostral direction, the obstruction will be found at the caudal end of the syrinx and vice versa. This also implies that the obstruction will most likely be found close to the largest diameter of the syrinx [22] (Fig. 9.6).
Due to the pulsatile movements of arachnoid septations, webs, or cysts, standard MRIs may not always be able to demonstrate an arachnopathy directly. With a history of spinal meningitis or subarachnoid hemorrhage [5], the often quite extensive arachnopathy is rather easy to diagnose by MRI (Fig. 9.7). Many arachnopathies, however, are quite discrete and extend over a few millimeters only (Fig. 9.6). Cardiac-gated cine MRI should be employed for such instances to study spinal CSF flow to identify areas of flow obstruction which may correspond to such circumscribed arachnoid pathologies [1, 22]. Sometimes significant flow signals can also be detected in the syrinx itself. In such cases, the highest flow velocities in the syrinx can be expected adjacent to the arachnoid scarring. The spinal cord should be studied with thin axial slices in T2-weighted images over the entire extent of the syrinx to search for areas of cord compression, displacement, or adhesion to the dura [7, 14, 22]. In the sagittal plane, the contour of the cord may appear distorted in areas of arachnoid scarring (Fig. 9.6). CISS (constructive interference in steady state) sequences can be used not only for the demonstration of the syrinx [12] but may also be helpful to detect arachnoid webs, scars, and cysts, because this technique is less susceptible to CSF flow artifacts [12]. Myelography and postmyelographic computer tomography (CT) are alternative methods to demonstrate arachnoid pathologies but have a lower sensitivity [22].
The sequence of events leading to a syrinx has implications not only for the neuroradiological appearance as just described but also for the evolution of clinical symptoms. The syrinx develops as a consequence of a series of events that originate from a pathology leading to CSF flow obstruction. For almost all entities leading to syrinx development, this process requires many years. Therefore, the first neurological symptoms in the patient’s history are commonly caused by this underlying pathology rather than the syrinx. In other words, a carefully taken clinical history can provide clues to the underlying pathology. If neurological signs spread to other parts of the body in an ascending pattern, the cause of the syrinx will be located at the lower pole of the syrinx and vice versa similar to the radiological evolution of the syrinx. Apart from trauma, arachnoid scarring may be related to infection [16] (Fig. 9.7), hemorrhage [5], irritation by outdated contrast agents such as pantopaque [28], or surgery, to mention a few [22].
It is always puzzling that patients may harbor a huge syrinx and yet have just minor symptoms with exactly the opposite observation for some smaller syrinx cavities associated with major neurological deficits. One explanation for this paradox may be that a great deal of the clinical problems are related to the underlying disease process causing the syrinx rather than to the syrinx itself [25]. This is particularly evident for syringomyelia associated with intramedullary tumors or cord tethering.
The classical symptom of syringomyelia is a dissociated sensory loss with loss of sensation for temperature and pain but preserved sensation for light touch. Pain related to syringomyelia is either permanent or aggravated by maneuvers such as coughing and sneezing and perceived in dermatomes corresponding to the level and extension of the syrinx. Syrinx pain represents neuropathic pain. In order to produce neuropathic pain, a syrinx must have reached the region of the dorsal horns close to the dorsal root entry zone. Quite commonly, patients report that their pain was associated with coughing or sneezing initially before becoming permanent. Other types of pain which patients report quite often, such as pain associated with exertion, cannot be explained by syringomyelia and are caused by other mechanisms such as muscular spanning to mention a common example. Late symptoms of syringomyelia are muscle atrophies corresponding to damage of ventral horn cells or trophic changes leading to skin and joint damages, particularly in the shoulder and elbow [25].
3 Management
Successful treatment of syringomyelia requires to treat the underlying cause – preferably before significant neurological deficits have developed. For syringomyelia associated with intramedullary tumors and Chiari I malformation, the rates for postoperative syrinx resolution are above 80 %, provided the tumor is removed and all components contributing to CSF flow obstruction in Chiari malformations have been surgically addressed, respectively [18, 20]. Syrinx cavities related to tethered cord syndromes tend to be of small caliber and extension. Therefore, complete untethering caused a postoperative reduction in just 13 %, whereas the syrinx remained unchanged in 87 % [19].
Successful treatment of syringomyelia related to spinal rather than craniocervical CSF flow obstructions is much more challenging. The underlying causes are more difficult to identify and to deal with surgically. For this reason, surgery on spinal arachnopathies for treatment of syringomyelia should be reserved for patients with progressive symptoms. Nevertheless, treating the cause of the syrinx with arachnolysis, untethering the cord, and duraplasty is rewarded by considerably better results compared to syrinx shunting procedures [21–23, 25, 33, 37].
Neuropathic pain and dysesthesias, particularly those of burning character, may be major clinical problems. Even though these may improve to some degree with successful treatment of the syrinx, this is never certain. Therefore, the decision for or against surgery should be based on the course of neurological signs and symptoms rather than pain syndromes alone [22].
In general, surgery can be recommended for patients with arachnoid scarring limited to about 2–3 spinal segments [22] (Fig. 9.5). All operations are performed in prone position. Laminotomies are recommended to reinsert the lamina at the end of the operation with titanium miniplates. After exposure of the dura, the extent of the arachnoid pathology and the syrinx can be visualized with ultrasound. Pulsations of syrinx fluid and CSF may become visible. Most importantly, the safest spot for opening of the dura can be chosen with this technique. As contamination of the CSF with blood may cause inflammatory reactions of the arachnoid, great care must be taken to achieve good hemostasis. For this purpose, the entire surgical field is covered by moist cottonoids, which keep soft tissues moist and soak up any minor bleeding. Then the dura is opened under the operating microscope in the midline without opening of the arachnoid. Once the dura is held open with sutures, the arachnoid pathology can be studied, and adequate exposure cranially and caudally is ensured in order to gain access to a normal and unaffected subarachnoid space on either end (Fig. 9.8a). Obviously, any surgeon should be familiar with the normal anatomy of the spinal subarachnoid space [34]. The posterior subarachnoid space is divided in two halves by a posterior longitudinal arachnoid septum. This septum extends between the outer arachnoid layer and an intermediate layer on the cord surface. The insertion on the cord surface is related to the midline dorsal vein. Further strands of arachnoid may be encountered in the posterior and lateral subarachnoid space. These arachnoid webs and septations are a physiological feature of the thoracic spinal canal. In the cervical area, the posterior longitudinal septum may be absent, and lateral arachnoid webs between nerve roots, which are considered to promote CSF flow in the thoracic spine, are not present. Under normal conditions, no arachnoid webs or septations exist in the entire anterior spinal subarachnoid space. A good landmark for dissection are the dentate ligaments, which originate from the spinal cord pia mater, run between posterior and anterior nerve roots, and insert close to the dural nerve root sleeve. With a microdissector, arachnoid and dura can be separated from each other without any problem in areas without arachnoid scarring, i.e., at either end of the exposure. In the area of scarring, sharp dissection with microscissors is usually required to achieve this (Figs. 9.8b, c). At the level of CSF flow obstruction, the arachnoid may become densely adherent to the cord surface. With opening of the rostral and caudal subarachnoid space, CSF flushes into the surgical field, and often the cord, which was distended by the syrinx, starts to pulsate, and the syrinx may collapse at this point. The arachnoid scar can be resected layer by layer leaving a last sheath on the cord surface to avoid injury to the cord or surface vessels (Figs. 9.8d, e). This last layer resembles the intermediate arachnoidal layer mentioned above. In this way, a free CSF passage in the posterior subarachnoid space can be created in every patient across the region of the arachnopathy. Dissection is then continued laterally on either side toward the dentate ligaments. This leads to a complete untethering of the cord in the majority of cases. No arachnoid dissection should be performed anteriorly of the dentate ligaments to avoid injuries to motor pathways and anterior spinal cord vessels. Closing the microsurgical part of the operation, an expansile duraplasty is inserted with a tight running suture and finally lifted up with tenting sutures on either side (Fig. 9.8f). To avoid scar formation and tethering between duraplasty and the spinal cord, alloplastic material for duraplasty should be preferred, i.e., Gore-Tex® (W.L. Gore & Associates GmbH, 85640 Putzbrunn, Germany). Special attention is finally paid to a good, tight closure of the muscle layer to prevent any CSF from entering the epifascial space. In patients who have been operated before, as in patients with posttraumatic syringomyelia who underwent spinal instrumentation, for instance, a lumbar drain is placed prophylactically if the soft tissue appears scarred and sparsely vascularized.
Considerable experience is needed to be successful with this surgical technique. The more focused the surgery, the less scarring may result. If unnecessary steps are taken, such as a too extensive dura opening, or the surgical field is contaminated with considerable amounts of blood, postoperative scarring may counterbalance completely the effect of surgery. On the other hand, if the dura opening is not extensive enough to gain access to the normal subarachnoid space above and below the level of scarring, the procedure is insufficient. As always, it is the right measure that counts and determines whether an operation will be successful or not.
For patients with more extensive arachnopathies after meningitis (Fig. 9.7), multiple intradural surgeries, or spinal subarachnoid hemorrhage, for example, surgery cannot provide a normal CSF passage anymore [22, 25]. Axial MRIs taken from the entire area of the arachnopathy should be evaluated in such instances for evidence of cord compression. Quite often, pouches and cysts have formed causing profound cord compression over a few spinal segments. Such compressions can be treated surgically by a wide fenestration of the corresponding arachnoid membranes. Such an operation can improve neurological symptoms related to the cord compression, but it will not influence the syrinx.
For that purpose, thecoperitoneal shunts have been introduced, which drain CSF from the subarachnoid space above the level of obstruction to the peritoneal cavity [29, 36, 45, 47, 48] (Fig. 9.7). For cavities extending into the cervical cord, ventriculoperitoneal shunts have been used for the same purpose [38, 50]. However, these shunts have their problems. There is little experience concerning the correct pressure settings other than to set them as low as possible avoiding signs of overdrainage or low intracranial pressure. Programmable shunts are sometimes used, but the shunt systems available are not specifically designed for this purpose. No data exist, as to how much tissue coverage may be allowed over the valve in order to still be able to change the setting with the programming device. This leaves the problem where to position the valve. Low-pressure valves have been used to overcome these problems. Five patients in the author’s series were treated that way. In one patient, a low-pressure valve was still not low enough, so that the valve was removed leaving the patient with a valveless drain. This worked for a year after which the catheter got blocked. Two patients do well clinically with a low-pressure valve even though the syrinx did not regress. The remaining two patients demonstrate a profound decrease of the syrinx with a favorable clinical response (Fig. 9.7).
For patients with a complete cord lesion, cordectomy is a very effective form of treatment for syringomyelia [6, 9, 15, 30, 41, 49] (Fig. 9.9). All patients treated in this manner in the author’s series improved neurologically with permanent resolution of the syrinx. However, the psychological burden for a patient to accept this operation should not be underestimated. Most patients prefer to undergo a decompression first. After all, this operation does provide good results in the majority of patients [9]. Patients will accept a cordectomy, however, if the ascending neurology cannot be arrested by decompression or shunting procedures and the neurological progress threatens important functions such as respiratory or hand muscles.
4 Results
Concentrating on patients with syringomyelia related to spinal arachnopathies, 150 patients with posttraumatic arachnoid scarring and 333 patients with nontraumatic arachnopathies were encountered in the author’s series. Reserving surgery for patients with progressive neurological symptoms led to operations for 73 patients with posttraumatic and 103 patients with nontraumatic arachnopathies (Table 9.2). Overall, 190 decompressions aiming at improving CSF flow and decompressing the spinal cord by resecting arachnoid pathologies were performed, while 11 patients with complete paraplegia underwent cordectomies, and 5 thecoperitoneal shunts were implanted. One patient received an opiate pump for his neuropathic pain syndrome. The remaining operations dealt with degenerative diseases of the cervical spine.
Concentrating on the 190 decompressions with arachnolysis and duraplasty, complications were observed in 18.5 %. The most common were wound infections in 4.2 % and postoperative urinary tract infections in 4.8 %. CSF fistulas were observed in just 1.8 %. Permanent surgical morbidity defined as permanent neurological worsening within 1 month after surgery occurred after seven operations, i.e., 3.7 %. A postoperative decrease of the syrinx was observed in 68.5 %, 25.9 % showed no postoperative change, while 5.6 % increased further despite surgery. After 3 months, 51.5 % considered their condition improved, 40.1 % as unchanged, and 8.4 % as worsened. Looking at individual symptoms revealed postoperative improvements for sensory deficits and pain, whereas motor weakness, gait, and sphincter functions were left unchanged.
Long-term results were determined with Kaplan-Meier statistics to determine the rates for progression-free survival after decompression. Overall, 65.8 % remained in a stable neurological status for 5 years after surgery. This rate was reduced to 47.6 % after 10 years. Looking at particular subgroups revealed good long-term results for patients with a focal nontraumatic arachnoid pathology not exceeding two spinal segments (Fig. 9.6) and for posttraumatic patients who had conceded no spinal cord injury at the time of the accident (Table 9.3) (Fig. 9.7). For these subgroups, significantly lower clinical recurrence rates were determined after 10 years.
Patients with extensive arachnoid pathologies or those with an incomplete spinal cord injury (Fig. 9.10), on the other hand, are the most difficult patients with spinal arachnopathies to treat. For patients with extensive arachnopathies after meningitis or intradural hemorrhages, the surgical concept of arachnolysis and duraplasty is as problematic as any other form of surgical treatment.
Thecoperitoneal shunts may reduce the ascending syrinx, but they hardly influence the myelopathy for which the arachnopathy itself is responsible (Fig. 9.7). The same applies to syrinx shunts. For patients with posttraumatic syringomyelia after an incomplete cord lesion, compromises as how far the arachnolysis and untethering of the cord should be pursued are unavoidable if surgical morbidity risking the remaining spinal cord functions is kept to a minimum (Fig. 9.10). It remains to be seen whether long-term results will improve with further experience. For patients with a posttraumatic syringomyelia who had suffered a complete spinal cord lesion at the time of their accident, results are more favorable, because a complete untethering and arachnolysis at the injury level can be performed without risking further neurological deficits (Fig. 9.11). If new symptoms appear postoperatively and the syrinx expands again, a cordectomy can always be performed later on (Fig. 9.9).
Conclusion
The diagnosis of syringomyelia should be reserved for patients with a space-occupying intramedullary cyst of progressive character and differentiated from such entities as a dilatation of the central canal or myelomalacia [13, 25, 40]. Syringomyelia is not a disease in its own right but a manifestation of a disorder of the spinal canal or craniocervical junction that has either resulted in an obstruction of CSF flow or spinal cord tethering or is associated with an intramedullary tumor. Management of patients with syringomyelia requires the correct diagnosis of the underlying disorder and the successful treatment of it. As this can be done in the vast majority of patients, no further surgical measures for the syrinx are required. Shunting the syrinx in particular can and should be avoided as the first line of treatment. The long-term prognosis depends on the therapeutic outcome of the underlying disorder.
References
Aghakhani N, Baussart B, David P et al (2010) Surgical treatment of posttraumatic syringomyelia. Neurosurgery 66:1120–1127; discussion 1127
Bilston LE, Fletcher DF, Brodbelt AR et al (2003) Arterial pulsation-driven cerebrospinal fluid flow in the perivascular space: a computational model. Comput Methods Biomech Biomed Engin 6:235–241
Bilston LE, Fletcher DF, Stoodley MA (2006) Focal spinal arachnoiditis increases subarachnoid space pressure: a computational study. Clin Biomech (Bristol, Avon) 21:579–584
Brodbelt AR, Stoodley MA, Watling AM et al (2003) Fluid flow in an animal model of post-traumatic syringomyelia. Eur Spine J 12:300–306
Eneling J, Bostrom S, Rossitti S (2011) Subarachnoid hemorrhage-associated arachnoiditis and syringomyelia. Clin Neuroradiol 22:169–173
Ewelt C, Stalder S, Steiger HJ et al (2010) Impact of cordectomy as a treatment option for posttraumatic and non-posttraumatic syringomyelia with tethered cord syndrome and myelopathy. J Neurosurg Spine 13:193–199
Falci SP, Indeck C, Lammertse DP (2009) Posttraumatic spinal cord tethering and syringomyelia: surgical treatment and long-term outcome. J Neurosurg Spine 11:445–460
Fischbein NJ, Dillon WP, Cobbs C et al (1999) The “presyrinx” state: a reversible myelopathic condition that may precede syringomyelia. AJNR Am J Neuroradiol 20:7–20
Gautschi OP, Seule MA, Cadosch D et al (2011) Health-related quality of life following spinal cordectomy for syringomyelia. Acta Neurochir (Wien) 153:575–579
Goldstein B, Hammond MC, Stiens SA et al (1998) Posttraumatic syringomyelia: profound neuronal loss, yet preserved function. Arch Phys Med Rehabil 79:107–112
Greitz D (2006) Unraveling the riddle of syringomyelia. Neurosurg Rev 29:251–263; discussion 264
Hirai T, Korogi Y, Shigematsu Y et al (2000) Evaluation of syringomyelia with three-dimensional constructive interference in a steady state (CISS) sequence. J Magn Reson Imaging 11:120–126
Holly LT, Batzdorf U (2002) Slitlike syrinx cavities: a persistent central canal. J Neurosurg Spine 97:161–165
Inoue Y, Nemoto Y, Ohata K et al (2001) Syringomyelia associated with adhesive spinal arachnoiditis: MRI. Neuroradiology 43:325–330
Kasai Y, Kawakita E, Morishita K et al (2008) Cordectomy for post-traumatic syringomyelia. Acta Neurochir (Wien) 150:83–86; discussion 86
Kaynar MY, Kocer N, Gencosmanoglu BE et al (2000) Syringomyelia – as a late complication of tuberculous meningitis. Acta Neurochir (Wien) 142:935–938; discussion 938–939
Klekamp J (2002) The pathophysiology of syringomyelia – historical overview and current concept. Acta Neurochir (Wien) 144:649–664
Klekamp J (2012) Surgical treatment of Chiari I malformation – analysis of intraoperative findings, complications, and outcome for 371 foramen magnum decompressions. Neurosurgery 71:365–380; discussion 380
Klekamp J (2011) Tethered cord syndrome in adults. J Neurosurg Spine 15:258–270
Klekamp J (2013) Treatment of intramedullary tumors: analysis of surgical morbidity and long-term results. J Neurosurg Spine 19:12–26
Klekamp J (2012) Treatment of posttraumatic syringomyelia. J Neurosurg Spine 17:199–211
Klekamp J (2012) Treatment of syringomyelia related to non-traumatic arachnoid pathologies of the spinal canal. Neurosurgery 72(3):376–389
Klekamp J, Batzdorf U, Samii M et al (1997) Treatment of syringomyelia associated with arachnoid scarring caused by arachnoiditis or trauma. J Neurosurg 86:233–240
Klekamp J, Samii M (2007) Surgery of spinal tumors. Springer, Heidelberg
Klekamp J, Samii M (2001) Syringomyelia – diagnosis and treatment. Springer, Heidelberg
Klekamp J, Samii M, Tatagiba M et al (1995) Syringomyelia in association with tumours of the posterior fossa. Pathophysiological considerations, based on observations on three related cases. Acta Neurochir (Wien) 137:38–43
Klekamp J, Völkel K, Bartels CJ et al (2001) Disturbances of cerebrospinal fluid flow attributable to arachnoid scarring cause interstitial edema of the cat spinal cord. Neurosurgery 48:174–185; discussion 185–186
Kubota M, Shin M, Taniguchi M et al (2008) Syringomyelia caused by intrathecal remnants of oil-based contrast medium. J Neurosurg Spine 8:169–173
Lam S, Batzdorf U, Bergsneider M (2008) Thecal shunt placement for treatment of obstructive primary syringomyelia. J Neurosurg Spine 9:581–588
Laxton AW, Perrin RG (2006) Cordectomy for the treatment of posttraumatic syringomyelia. Report of four cases and review of the literature. J Neurosurg Spine 4:174–178
Lohle PN, Wurzer HA, Hoogland PH et al (1994) The pathogenesis of syringomyelia in spinal cord ependymoma. Clin Neurol Neurosurg 96:323–326
Milhorat TH, Capocelli AL Jr, Kotzen RM et al (1997) Intramedullary pressure in syringomyelia: clinical and pathophysiological correlates of syrinx distension. Neurosurgery 41:1102–1110
Morisako H, Takami T, Yamagata T et al (2011) Focal adhesive arachnoiditis of the spinal cord: imaging diagnosis and surgical resolution. J Craniovertebr Junction Spine 1:100–106
Nicholas DS, Weller RO (1988) The fine anatomy of the human spinal meninges. A light and scanning electron microscopy study. J Neurosurg 69:276–282
Olivier A, Tran Quan VaN (1955) A case of monstrous post-traumatic hypertrophy of the foot, of true syringomyelic type. J Radiol Electrol Arch Electr Medicale 36:808–810
Oluigbo CO, Thacker K, Flint G (2010) The role of lumboperitoneal shunts in the treatment of syringomyelia. J Neurosurg Spine 13:133–138
Parker F, Aghakhani N, Tadie M (1999) Non-traumatic arachnoiditis and syringomyelia. A series of 32 cases. Neurochirurgie 45(Suppl 1):67–83
Piatt JH Jr (2005) Progressive syringomyelia controlled by treatment of associated hydrocephalus in an infant with birth injury. Case report. J Neurosurg 103:198–202
Reddy KK, Del Bigio MR, Sutherland GR (1989) Ultrastructure of the human posttraumatic syrinx. J Neurosurg 71:239–243
Roser F, Ebner FH, Sixt C et al (2010) Defining the line between hydromyelia and syringomyelia. A differentiation is possible based on electrophysiological and magnetic resonance imaging studies. Acta Neurochir (Wien) 152:213–219; discussion 219
Sgouros S, Williams B (1996) Management and outcome of posttraumatic syringomyelia. J Neurosurg 85:197–205
Squier MV, Lehr RP (1994) Post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry 57:1095–1098
Stoodley MA, Gutschmidt B, Jones NR (1999) Cerebrospinal fluid flow in an animal model of noncommunicating syringomyelia. Neurosurgery 44:1065–1075; discussion 1075–1066
Stoodley MA, Jones NR, Yang L et al (2000) Mechanisms underlying the formation and enlargement of noncommunicating syringomyelia: experimental studies. Neurosurg Focus 8:E2
Suzuki S, Chiba Y, Hidaka K et al (1998) A new operative technique of posttraumatic syringomyelia: thecoperitoneal shunt. No Shinkei Geka 26:541–546
Tobimatsu Y, Nihei R, Kimura T et al (1991) A quantitative analysis of cerebrospinal fluid flow in posttraumatic syringomyelia. Nippon Seikeigeka Gakkai Zasshi 65:505–516
Vassilouthis J, Papandreou A, Anagnostaras S (1994) Thecoperitoneal shunt for post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry 57:755–756
Vengsarkar US, Panchal VG, Tripathi PD et al (1991) Percutaneous thecoperitoneal shunt for syringomyelia. Report of three cases. J Neurosurg 74:827–831
Williams B (1990) Post-traumatic syringomyelia, an update. Paraplegia 28:296–313
Williams B, Sgouros S, Nenji E (1995) Cerebrospinal fluid drainage for syringomyelia. Eur J Pediatr Surg 5(Suppl 1):27–30
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Klekamp, J. (2017). Syringomyelia. In: Weidner, N., Rupp, R., Tansey, K. (eds) Neurological Aspects of Spinal Cord Injury. Springer, Cham. https://doi.org/10.1007/978-3-319-46293-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-46293-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46291-2
Online ISBN: 978-3-319-46293-6
eBook Packages: MedicineMedicine (R0)